Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3367

Actual shortage: 219 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3138 (93%)

Discontinuation Reports

365

To be discontinued: 24 (7%)
Discontinued: 341 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

68 (28%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-QUETIAPINE 100MG TABLET Resolved 2019-12-05 2019-12-09 100317
APO-QUETIAPINE 25MG TABLET Resolved 2018-12-27 2020-10-24 70537
APO-QUETIAPINE 25MG TABLET Resolved 2021-04-30 2021-05-31 138352
APO-QUETIAPINE 100MG TABLET Resolved 2021-05-14 2021-05-31 139416
APO-QUETIAPINE 300MG TABLET Resolved 2021-05-14 2021-06-07 139419
APO-QUETIAPINE 100MG TABLET Actual shortage 2021-06-11 2021-08-27 140785
APO-QUETIAPINE 200MG TABLET Actual shortage 2021-06-11 2021-08-27 140788
APO-QUETIAPINE 200MG TABLET Resolved 2021-06-25 2021-08-25 141543
APO-QUETIAPINE 25MG TABLET Actual shortage 2021-08-27 2021-08-27 144776
APO-QUETIAPINE 300MG TABLET Actual shortage 2021-08-27 2021-08-27 144779
APO-QUETIAPINE FUMARATE 25MG TABLET (IMMEDIATE RELEASE) Resolved 2023-03-09 2023-04-14 186586
APO-QUETIAPINE FUMARATE 25MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-02-23 216699
APO-QUETIAPINE FUMARATE 100MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-09-05 216702
APO-QUETIAPINE FUMARATE 200MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-09-05 216705
APO-QUETIAPINE FUMARATE 300MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-02-23 216708
APO-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-12-08 2024-01-19 212969
APO-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-11-14 216687
APO-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-05-31 216690
APO-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-11-14 216693
APO-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-07-18 216696
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LOSARTAN/HCTZ 12.5MG 50MG TABLET Discontinued 2018-09-07 2018-12-28 60603
APO-LOSARTAN/HCTZ 25MG 100MG TABLET Discontinued 2018-09-10 2018-12-28 60997
APO-LOSARTAN/HCTZ 12.5MG 100MG TABLET Discontinued 2018-11-19 2018-11-19 67146
APO-MELOXICAM 7.5MG TABLET Discontinued 2018-09-07 2018-09-15 60612
APO-MEMANTINE 10MG TABLET Discontinued 2018-09-07 2018-09-15 60615
APO-METFORMIN - TAB 500MG 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40781
APO-METFORMIN - TAB 500MG 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40784
APO-METFORMIN - TAB 500MG 500MG TABLET Discontinued 2018-02-23 2018-11-26 40790
APO-METFORMIN 850 MG TABLETS 850MG TABLET Discontinued 2018-02-23 2019-06-12 40778
APO-METFORMIN 850 MG TABLETS 850MG TABLET Discontinued 2018-02-23 2018-09-15 40796
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Discontinued 2019-01-04 2019-01-04 71207
APO-METOCLOP TAB 10MG 10MG TABLET Discontinued 2017-03-13 2017-03-13 1101
APO-METOCLOP TAB 5MG 5mg tablet Discontinued 2017-03-13 2017-03-13 1105
APO-METOPROLOL 25MG TABLET To be discontinued 2018-09-07 2021-06-03 60628
APO-MYCOPHENOLATE 250MG CAPSULE Discontinued 2018-09-07 2018-09-15 60637
APO-MYCOPHENOLATE 500MG TABLET Discontinued 2018-09-07 2018-10-12 60640
APO-NAPRO-NA 275MG TABLET Discontinued 2018-09-08 2018-09-15 60657
APO-NAPRO-NA DS 550MG TABLET Discontinued 2018-09-08 2018-09-15 60660
APO-NAPROXEN 250MG TABLET Discontinued 2018-09-08 2018-09-15 60666
APO-NEVIRAPINE XR 400MG TABLET (EXTENDED-RELEASE) Discontinued 2019-03-11 2019-03-11 78257